Zydus Cadila has launched its new anti-diabetic drug, Tenglyn, a generic oral version of gliptins at the most affordable price of Rs. 7 per tablet in India.

‘The new anti-diabetic drug, Tenglyn offered at a price of rs.7 per tablet will be a boon for 60 million diabetic patients in India.’

"With Tenglyn we provide patients suffering from diabetes access to this advanced treatment at the most affordable cost," said Sharvil Patel, Deputy Managing Director, Zydus Cadila.




Therefore, this new launch of the same drug at a cost of rs.7 will help 60 million diabetic patients economically. The cost-effective drug will also be made easily accessible all over the country. The price of Zydus is said to be one sixth of all other pharmaceutical companies.
Source-Medindia